デフォルト表紙
市場調査レポート
商品コード
1492247

ビサコジル市場:投与タイプ、用途、流通チャネル別-2024-2030年の世界予測

Bisacodyl Market by Administration Type (Oral Medications, Suppository Medications), Application (Constipation, Neurogenic Bowl Dysfunction), Distribution Channels - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 180 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.74円
ビサコジル市場:投与タイプ、用途、流通チャネル別-2024-2030年の世界予測
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ビサコジル市場規模は2023年に12億8,000万米ドルと推計され、2024年には13億5,000万米ドルに達し、CAGR 6.49%で2030年には19億9,000万米ドルに達すると予測されています。

ビサコジルは、便秘治療や検査・処置前の腸内洗浄に使用される刺激性下剤であり、ヘルスケアプロバイダーと消費者の両方が幅広く利用できるよう、さまざまなチャネルを通じて流通しています。こうした流通経路を理解することは、医薬品・ヘルスケア市場の利害関係者にとって不可欠です。ビサコジルの採用を加速させる便秘と神経因性腸機能障害の有病率の上昇。また、ちょっとした健康問題に対する市販薬への嗜好が高まっていることも、市場成長の要因となっています。しかし、ビサコジルの製造に使用される原材料コストの変動が市場成長に影響を与えています。さらに、患者のコンプライアンスと快適性を高める胃に強い錠剤や時間放出カプセルのような革新的なドラッグデリバリーシステムの開発は、市場成長に大きな機会をもたらします。

主な市場の統計
基準年[2023] 12億8,000万米ドル
予測年[2024] 13億5,000万米ドル
予測年 [2030] 19億9,000万米ドル
CAGR(%) 6.49%

地域別インサイト

南北アメリカ、特に米国とカナダでは、便秘解消のための一般用医薬品(OTC)に対する消費者の意識が非常に高いです。米国市場は、FDAによる製品に対する強力な規制支援が特徴で、イノベーションを促進し、製品の安全性を確保しています。カナダも同様の規制環境にあり、安定した市場需要につながっています。EU諸国は規制政策が厳しく、ビサコジルの市場が確立されており、主に臨床現場で使用され、市販されています。一方、中東とアフリカは新興市場であり、ヘルスケア・インフラの改善と医薬品部門への投資の増加により、潜在的な成長が見込まれています。規制上のハードルは依然として課題であるが、戦略的パートナーシップの機会を提供しています。アジア太平洋地域では、中国、日本、インドが主要なプレーヤーです。中国のビサコジル市場は、ヘルスケアへの大規模投資により急速に拡大しています。高齢化が進む日本では、ビサコジルを含む下剤の需要が安定しています。インドは新興市場であり、消費者の健康意識の高まりと医薬品セクターの拡大がビサコジルの売上を牽引しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、ビサコジル市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、事業戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront(F)、Pathfinder(P)、Niche(N)、Vital(V)に分類されます。

市場シェア分析

市場シェア分析は、ビサコジル市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。

戦略分析と推奨

戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、ビサコジル市場における現在の立ち位置を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 便秘と神経性腸機能障害の有病率の上昇
      • 市販薬の採用増加ビサコジル
    • 抑制要因
      • ビサコジルの製造に使用される原材料の変動価格
    • 機会
      • 革新的な薬剤処方と投与方法の継続的な調査開発
      • 製造方法における技術的進歩
    • 課題
      • ビサコジルの代替品の可用性
  • 市場セグメンテーション分析
    • 投与タイプ:市販の経口薬(OTC)の大幅な採用ビサコジル
    • 応用:便秘および神経性腸機能障害の管理におけるビサコジルの利用率の向上
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 ビサコジル市場管理タイプ別

  • 経口薬
  • 坐薬

第7章 ビサコジル市場:用途別

  • 便秘
  • 神経性腸機能障害

第8章 ビサコジル市場流通チャネル別

  • 病院薬局
  • オンライン薬局
  • 小売薬局

第9章 南北アメリカのビサコジル市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のビサコジル市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのビサコジル市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • アッヴィ、米国FDAにリンゼス(リナクロチド)の6~17歳の小児および青少年の機能性便秘に対する新たな適応症の追加申請を提出
  • 戦略分析と提言

第13章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. BISACODYL MARKET RESEARCH PROCESS
  • FIGURE 2. BISACODYL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BISACODYL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BISACODYL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BISACODYL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BISACODYL MARKET DYNAMICS
  • FIGURE 7. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BISACODYL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. BISACODYL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BISACODYL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BISACODYL MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BISACODYL MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BISACODYL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BISACODYL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BISACODYL MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BISACODYL MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BISACODYL MARKET SIZE, BY SUPPOSITORY MEDICATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BISACODYL MARKET SIZE, BY SUPPOSITORY MEDICATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BISACODYL MARKET SIZE, BY CONSTIPATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BISACODYL MARKET SIZE, BY CONSTIPATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BISACODYL MARKET SIZE, BY NEUROGENIC BOWL DYSFUNCTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BISACODYL MARKET SIZE, BY NEUROGENIC BOWL DYSFUNCTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BISACODYL MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BISACODYL MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BISACODYL MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BISACODYL MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BISACODYL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BISACODYL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 36. ARGENTINA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 41. BRAZIL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 42. BRAZIL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 47. CANADA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. CANADA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 53. MEXICO BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. MEXICO BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 59. UNITED STATES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. UNITED STATES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. AUSTRALIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 81. CHINA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. CHINA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 87. INDIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. INDIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 93. INDONESIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. INDONESIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 99. JAPAN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. JAPAN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 105. MALAYSIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. MALAYSIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. PHILIPPINES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 117. SINGAPORE BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. SINGAPORE BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. SOUTH KOREA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 129. TAIWAN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. TAIWAN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 135. THAILAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. THAILAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 141. VIETNAM BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. VIETNAM BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 155. DENMARK BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. DENMARK BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 161. EGYPT BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. EGYPT BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 167. FINLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. FINLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 173. FRANCE BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. FRANCE BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 179. GERMANY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. GERMANY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 185. ISRAEL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. ISRAEL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 191. ITALY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. ITALY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. NETHERLANDS BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 203. NIGERIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. NIGERIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 209. NORWAY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. NORWAY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 215. POLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. POLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 221. QATAR BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. QATAR BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 227. RUSSIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. RUSSIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. SAUDI ARABIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH AFRICA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 245. SPAIN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. SPAIN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 251. SWEDEN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. SWEDEN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. SWITZERLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 263. TURKEY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. TURKEY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED KINGDOM BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM BISACODYL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM BISACODYL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 281. BISACODYL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 282. BISACODYL MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-BF5906741E5D

[180 Pages Report] The Bisacodyl Market size was estimated at USD 1.28 billion in 2023 and expected to reach USD 1.35 billion in 2024, at a CAGR 6.49% to reach USD 1.99 billion by 2030.

Bisacodyl is a stimulant laxative used for treating constipation and for bowel clearance before medical examinations & procedures; it is distributed through a variety of channels to ensure wide availability for both healthcare providers and consumers. Understanding these distribution channels is essential for stakeholders within the pharmaceutical and healthcare markets. Rising prevalence of constipation and neurogenic bowel dysfunction accelerating the adoption of bisacodyl. In addition, increasing preference for over-the-counter remedies for minor health issues owing to market growth. However, the volatile costs of raw materials used in the manufacturing of bisacodyl impact the market growth. Furthermore, developing innovative drug delivery systems such as gastro-resistant tablets or time-release capsules enhancing patient compliance and comfort poses significant opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.28 billion
Estimated Year [2024] USD 1.35 billion
Forecast Year [2030] USD 1.99 billion
CAGR (%) 6.49%

Regional Insights

In the Americas, especially in the United States and Canada, consumer awareness about over-the-counter (OTC) medications for constipation relief is quite high. The United States market is characterized by strong regulatory support from the FDA for bisacodyl products, fostering innovation and ensuring product safety. Canada shares a similar regulatory environment, leading to a stable market demand. The EU countries, with their stringent regulatory policies, have a well-established market for bisacodyl, primarily utilized in clinical settings and available over the counter. The Middle East and Africa, however, represent emerging markets with potential growth attributed to improving healthcare infrastructure and increasing investments in the pharmaceutical sector. Regulatory hurdles remain a challenge yet offer opportunities for strategic partnerships. China, Japan, and India are key players in the Asia-Pacific region. China's bisacodyl market is expanding rapidly due to massive investments in healthcare. Japan, with its aging population, exhibits a consistent demand for laxatives, including bisacodyl. India is an emerging market, with rising consumer health awareness and an expanding pharmaceutical sector driving bisacodyl sales.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Bisacodyl Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising prevalence of constipation and neurogenic bowel dysfunction
      • Increasing adoption of over-the-counter bisacodyl drug
    • Market Restraints
      • Volatile prices of raw materials used in manufacturing of bisacodyl
    • Market Opportunities
      • Ongoing research & developments for innovative drug formulation and delivery methods
      • Technological advancements in manufacturing methods
    • Market Challenges
      • Availability of alternative to bisacodyl
  • Market Segmentation Analysis
    • Administration Type: Significant adoption of over-the-counter (OTC) oral bisacodyl
    • Application: Increasing utilization of bisacodyl in managing constipation and neurogenic bowel dysfunction
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Bisacodyl Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Bisacodyl Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS (linaclotide) for Functional Constipation in Children and Adolescents 6 to 17 Years of Age

AbbVie has revealed the submission of a supplemental New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) aimed at expanding the indications of Linzess (linaclotide) to include the therapy of functional constipation in pediatric patients aged between 6 to 17 years. This strategic move broadens the therapeutic scope of Linzess, previously approved for adults with irritable bowel syndrome with constipation and chronic idiopathic constipation, tapping into a younger demographic suffering from similar bowel management issues. [Published On: 2022-12-16]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Bisacodyl Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Bisacodyl Market, highlighting leading vendors and their innovative profiles. These include Cambrex Corporation, Carbogen AMCIS, Centurion Remedies Private Limited, Cipla Limited, Dr. Reddy's Laboratories, Enomark, Erregierre Spa, GlaxoSmithKline plc, Joshi Agrochem Pharma, Kreative Organics Private Limited, Lexicare Pharma Pvt. Ltd., LMG Pharma, Mahendra Chemicals, Manus Aktteva Biopharma LLP, Merck KGaA, Sanofi S.A., Tiefenbacher API + Ingredients GmbH & Co. KG, and Zuche Pharmaceuticals Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Bisacodyl Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Administration Type
    • Oral Medications
    • Suppository Medications
  • Application
    • Constipation
    • Neurogenic Bowl Dysfunction
  • Distribution Channels
    • Hospital Pharmacy
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of constipation and neurogenic bowel dysfunction
      • 5.1.1.2. Increasing adoption of over-the-counter bisacodyl drug
    • 5.1.2. Restraints
      • 5.1.2.1. Volatile prices of raw materials used in manufacturing of bisacodyl
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research & developments for innovative drug formulation and delivery methods
      • 5.1.3.2. Technological advancements in manufacturing methods
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative to bisacodyl
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Administration Type: Significant adoption of over-the-counter (OTC) oral bisacodyl
    • 5.2.2. Application: Increasing utilization of bisacodyl in managing constipation and neurogenic bowel dysfunction
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Bisacodyl Market, by Administration Type

  • 6.1. Introduction
  • 6.2. Oral Medications
  • 6.3. Suppository Medications

7. Bisacodyl Market, by Application

  • 7.1. Introduction
  • 7.2. Constipation
  • 7.3. Neurogenic Bowl Dysfunction

8. Bisacodyl Market, by Distribution Channels

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Bisacodyl Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bisacodyl Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bisacodyl Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS (linaclotide) for Functional Constipation in Children and Adolescents 6 to 17 Years of Age
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio